10 completed. 10 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Completed 10 |
Follow Vitiligo: new trials by email Literature Review of Vitiligo trials Research Report on Vitiligo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Value of Methotrexate in NCES for Stable Vitiligo Non cultured epidermal suspension - Vitiligo | Phase 4 | Completed | Cairo University | 21 | 2026-03-03 | 2026-09-30 |
| Oral Mini Pulse Dexamethasone in Pediatric Vitiligo Dexamethasone (0.1 mg/kg) - Vitiligo | Phase 4 | Completed | Cairo University | 22 | 2026-02-28 | 2026-09-01 |
| Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial ruxolitinib cream - Vitiligo | Phase 4 | Completed | Dow University of Health Sciences | 120 | 2025-04-06 | 2026-01-26 |
| A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients. Narrow Band UVB Treatment, blue light emitting diode - Vitiligo | Phase 4 | Completed | Cairo University | 30 | 2025-01-20 | 2025-09-15 |
| Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo diphenylcyclopropenone (DPCP) - Vitiligo | Phase 4 | Completed | Ain Shams University | 20 | 2021-01-17 | 2023-04-11 |
| Secukinumab in Active Non-segmental Vitiligo Secukinumab - Vitiligo, Secukinumab | Phase 4 | Completed | University Hospital, Ghent | 8 | 2016-10-12 | 2023-02-10 |
| Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients ReCell, Full surface CO2 laser 200 mJ, Full surface CO2 laser 150 mJ - Segmental Vitiligo, Piebaldism | Phase 4 | Completed | Netherlands Institute for Pigment Disorders | 10 | 2015-05-01 | 2017-04-04 |
| NB-UVB and PUVA Vitiligo Study Phototherapy, Phototherapy and Photochemotherapy - Vitiligo | Phase 4 | Completed | Henry Ford Health System | 10 | 2013-03-01 | 2017-02-23 |
| Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) topical tacrolimus treatment, topical pimecrolimus treatment, local mometasone furoate treatment - Vitiligo | Phase 4 | Completed | University Hospital, Ghent | 14 | 2010-02-16 | 2022-12-08 |
| Botulinum Toxin Treatment for Localized Vitiligo Botulinum toxin A - Vitiligo | Phase 4 | Completed | King Saud University | 10 | 2009-04-01 | 2010-01-18 |
Piebaldism (1)
Hypopigmentation (10) · Pigmentation Disorders (10) · Skin Diseases (10) · Skin and Connective Tissue Diseases (10) · Albinism (1) · Amino Acid Metabolism, Inborn Errors (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Nutritional and Metabolic Diseases (1) · Skin Diseases, Genetic (1)
Botulinum Toxins, Type A (1) · Dexamethasone (1) · Photochemotherapy (1) · Phototherapy (1) · diphenylcyclopropenone (1) · secukinumab (1)
Cairo University (3) · University Hospital, Ghent (2) · Ain Shams University (1) · Dow University of Health Sciences (1) · Henry Ford Health System (1) · King Saud University (1) · Netherlands Institute for Pigment Disorders (1)
Egypt (4) · Belgium (2) · Netherlands (1) · Pakistan (1) · Saudi Arabia (1) · United States (1)
Albert Wolkerstorfer, MD, PhD (1) · Ghada Binsaif, MD (1) · Iltefat Hamzavi, MD (1) · Marwa MA Abdallah (1) · Menno A. De Rie, MD, PhD (1) · Nanny Van Geel, MD, PhD (1) · Rania M Elhusseiny (1) · van Geel Nanja, MD, PhD (1)